ProLogium and TDAC Enter Merger Agreement Valued at Approximately $3.8B
ProLogium and Translational Development Acquisition (TDAC) announced they have entered into a definitive agreement for a business combination that would result in ProLogium becoming a publicly listed company. Upon closing of the transaction, the combined company will be named ProLogium Technology and is expected to be listed on the Nasdaq under the ticker symbol (PRLG). The transaction values ProLogium at approximately $3.8B on a pre-money, net cash-free basis. ProLogium will seek funding by a combination of TDAC's cash in trust and proceeds from a targeted common equity PIPE. The boards of directors of both ProLogium and TDAC have approved the transaction, which is expected to close in the second half of 2026, subject to approval by the shareholders of both ProLogium and TDAC, regulatory approvals, and other customary closing conditions.
